Meeting
2016 ASCO Annual Meeting
Validation of the JCOG prognostic index in advanced gastric cancer of the SPIRITS and G-SOX trials, using individual patient data.
Authors
Daisuke Takahari
Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
Daisuke Takahari , Junki Mizusawa , Wasaburo Koizumi , Ichinosuke Hyodo , Narikazu Boku
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4026)
DOI
10.1200/JCO.2016.34.15_suppl.4026
Abstract #
4026
Poster Bd #
18
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The new prognostic index of advanced gastric cancer using the data from JCOG1013.
First Author: Daisuke Takahari
Poster
2020 Gastrointestinal Cancers Symposium
Prognostic factor of nivolumab for advanced gastric cancer patients with poor performance status patients.
First Author: Toshihiko Matsumoto
Poster
2018 Gastrointestinal Cancers Symposium
Is there a role for histology based treatment choice in advanced gastric cancer (GC)?
First Author: Rosalba Barile
Poster
2015 Gastrointestinal Cancers Symposium
Prognostic factors for PFS in patients with advanced gastric cancer: Using the data from JCOG9912 study.
First Author: Daisuke Takahari